ALLERGIC RHINITIS: NEW APPROACHES TO THERAPY

Abstract

This article focuses on new approaches to the therapy of allergic rhinitis (AR), a chronic inflammatory condition caused by allergens such as pollen, dust mites, and animal dander. AR is characterized by symptoms like nasal congestion, sneezing, and itching, which significantly impact patients' quality of life. Moreover, the article highlights innovative therapeutic strategies, including biologic agents like omalizumab and dupilumab, which target specific immune pathways, and allergen-specific immunotherapy (ASIT), which addresses the root cause of AR by inducing immune tolerance. This article highlights these new therapeutic strategies and their potential impact on the management of allergic rhinitis.